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Mitral Transapical Transcatheter Valve-in-Valve Implantation Using The
Braile Inovare Prosthesis
Diego F. Gaia,1 Matheus S. Santos,1 Danny Dvir,2 Joao R. Breda,1
Murilo Macedo,1 Carolina Baeta,1 Jose Augusto Marcondes,1
Jose Honorio Palma,1 Enio Buffolo1
1Escola Paulista de Medicina - UNIFESP, Sao Paulo, Sao Paulo; 2St Paul’s
Hospital, Vancouver, Canada, Vancouver, Canada
BACKGROUND Reoperative procedure for the substitution of failed
mitral bioprosthesis is a procedure that might involve considerable
risk. In some special cases with selected risk factors, mortality is high
and might even contraindicate the procedure. The minimally invasive
valve-in-valve transcatheter transapical mitral valve implant offers an
alternative, reducing morbidity and mortality. The objective of this
paper is the evaluation of these implants using the Braile Inovare
prosthesis.
METHODS The transcatheter balloon-expandable Braile Inovare
prosthesis was used in 12 cases, with an average EuroSCORE of 20.1%.
Procedures were performed in a hybrid operative room, under ﬂuo-
roscopic and echocardiographic control. Through left mini-
thoracotomy, the prostheses were implanted through the cardiac
apex, under rapid pacing. Seriated echocardiographic and clinical
controls were performed. Follow-up varied from 1 to 30 months.
RESULTS Correct prosthesis release took place in all cases. In one
case, there was need for right lateral thoracotomy for the release of an
embolized prosthesis. There was no operative mortality. 30 day
mortality was of one case (8.3%). Ejection fraction showed a signiﬁ-
cant improvement after the 7th post-operative day and the aortic
gradient also showed a reduction. Residual mitral regurgitation was
not present. There was no peripheral vascular complication or com-
plete atrioventricular block.
CONCLUSIONS The mitral valve-in-valve transcatheter implant in
failed bioprosthesis is a safe procedure, with low morbidity and
mortality. This possibility might alter prosthesis selection in the initial
surgical prosthesis selection, favoring bioprostheses.
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Association of Learning Curve with Procedural Results and Recurrence of
Mitral Regurgitation After Percutaneous Mitral Valve Repair with MitraClip
System
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BACKGROUND Percutaneous mitral valve edge-to-edge repair using
the MitraClip system has been widespread for signiﬁcant mitral
regurgitation (MR) patients with high surgical risk. Learning curve isan important concern for the institute which introduce the MitraClip
procedure in the future. In this study, the effect of learning curve on
the procedural results and recurrent MR was investigated.
METHODS From November 2005 to October 2013, 174 patients un-
derwent the MitraClip procedure in our institute. These patients were
classiﬁed into ﬁrst 50 patients (period 1), second 50 patients (period
2), and the other 74 patients (period 3), and learning curve was eval-
uated by comparison of procedural results and the subsequent
recurrence of MR between the 3 groups. All MitraClip procedures were
performed by or under the supervision of a single operator (S. Kar).
RESULTS Fluoroscopic time was 45.1  18.2 min in period 1, 42.7 
23.1 min in period 2, and 34.8  13.8 min in period 3, and signiﬁcantly
decreased from period 1 to period 3 (p¼0.007). The number of clips
was 1.38  0.57 in period 1, 1.48  0.51 in period 2, and 1.60  0.52 in
period 3 (p¼0.07). Although acute procedural success (residual MR
</¼2þ immediately after the procedure) was similarly achieved in the
3 groups (94.0% vs. 94.0% vs. 98.6%, p¼0.31), the distribution of re-
sidual MR grade after the procedure was signiﬁcantly better in period
3 than in period 1 (p¼0.04). Among patients with acute procedural
success, recurrent MR within 1 year was observed more frequently in
period 1 (38.3%) than in period 2 (10.6%, p¼0.002) and period 3 (15.3%,
p¼0.004).
CONCLUSIONS Learning curve of the MitraClip procedure was
observed in terms of procedural quality and device durability. When
starting the MitraClip program, these ﬁndings should be considered.
CATEGORIES STRUCTURAL: Valvular Disease: Mitral
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Accuracy and Procedural Characteristics of Radiofrequency Compared
With Standard Needle Transseptal Puncture for Structural Heart
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BACKGROUND Targeted transseptal (TS) puncture is an essential
technique for many structural heart interventions. Spatial accuracy of
standard versus radiofrequency (RF) needles has not previously been
reported.
METHODS Consecutive patients undergoing left-sided structural
heart interventions requiring TS puncture were included in an
ongoing registry. The BRK needle (St Jude Med) paired with Mullins
sheath (Medtronic) was used alternately with RF needle (Baylis Med)
paired with SL1 Sheath (St Jude Med). Procedural times were: (1)
withdrawing the TS system from the SVC and positioning at the
intended TS site; (2) time to cross septum once site was selected; (3)
time to advance the sheath across the septum. Transesophageal
echocardiographic (TEE) measurements of intended versus ﬁnal TS
crossing site on the septum were obtained. These measurements were
made from reproducible edges of the visible portions of the fossa
ovalis and/or interatrial septum to the TS site in bicaval and short axis
(SAX) TEE views both pre and post TS puncture. Pre puncture and
maximal tenting of the septum were also quantiﬁed.
RESULTS 25 patients underwent standard needle and 27 RF needle TS
access. 2 patients crossed over from the standard needle group to the
RF group due to inability to puncture. Data is reported in an “as
treated” analysis. Left-sided heart interventions included the Mitra-
Clip (N¼35), Watchman (N¼9), and Lariat (N¼7) procedures and
percutaneous balloon mitral valvuloplasty (N¼1). The principal ﬁnd-
ings are shown in the Table. TS procedural times signiﬁcantly favored
the RF needle for time from septum to puncture. Both standard and
RF access yielded accurate crossing technique with no statistical
differences between the intended and actual crossing site. Maximal
tenting was signiﬁcantly less with the RF needle. Few patients had
challenging atrial anatomy such as atrial septal aneurysm, thickened
septum primum or prior TS attempts. 2 patients in the standard arm
required the mandril wire for assistance to cross. There were no
major complications.
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Septum to puncture
(sec)43  40 22  22 0.02Puncture to cross (sec) 22  9 22  11 1
Absolute jPre-Postj
DifferenceSuperior Rim to TS site
(mm)0.8  0.9 1.0  1.2 0.24Inferior Rim to TS site
(mm)0.7  0.6 1.1  1.2 0.12Anterior Rim to TS site
(mm)1.8  2.0 1.4  1.6 0.45Posterior Rim to TS
site (mm)1.3  1.8 1.3  1.5 0.97Pre-to-max Tent TS
site (mm)4.7  3.0 2.8  2.8 0.02CONCLUSIONS Procedural times and degree of septum tenting
favored the RF over standard needle; however, accuracy was similar
with both approaches. RF was a successful strategy when standard
needle failed. There were no major complications with either TS
puncture strategy.
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TCT-704
Mitral Annular Calciﬁcation Does Not Impact MitraClip Procedural Success
and Is Not Associated with Durability of Repair
Emily Tat,1 Richard Cheng,1 Reza Arsanjani,1 Robert Siegel,1
Asma Hussaini,1 Alfredo Trento,1 Saibal Kar1
1Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND Mitral annular calciﬁcation (MAC) has been associated
with coronary atherosclerosis and increased mortality. While patients
(pts) undergoing percutaneous edge-to-edge repair of mitral regurgi-
tation (MR) often have signiﬁcant MAC, the impact of MAC on pro-
cedural success and durability of repair is not known.
METHODS Pts who underwent percutaneous repair of MR between
April 2009 and May 2014 with the MitraClip device (Abbott Vascular,
Santa Clara, CA) were included in the analysis. Procedural success was
deﬁned as a reduction of MR of 2 grades or more on transthoracic
echocardiogram done prior to discharge. A second metric of proce-
dural success was a reduction of MR to less than or equal to mild-to-
moderate. Durability of repair was deﬁned as successful retention of
procedural success at 1-yr transthoracic echocardiogram. Pts were
graded as having mild MAC if annular calciﬁcation involved one-third
or less of the posterior annulus, or moderate or severe if it involved
more. Procedural success was compared across severities of MAC, and
durability of repair was compared between pts with no or mild MAC
and those with moderate or severe MAC.
RESULTS 173 pts were included in the analysis. Mean age at percu-
taneous repair was 76.9  12.6 yrs and 40.8% were females. Hemo-
dialysis and coronary artery disease was present in 10/173 (5.8%) and
94/173 (54.3%) of pts, respectively. Pts with MAC were older 79.9 
10.1 vs. 74.3  14.0 yrs (p¼0.003). MR was moderate-to-severe in 35/
173 (20.2%) of pts and severe in 138/173 (79.8%) of pts. Procedural
success of reduction of MR of 2 grades or more was obtained in 81/87
(93.1%) pts with no MAC, 60/61 (98.4%) pts with mild MAC, and 24/25
(96.0%) pts with moderate or severe MAC (p¼0.321). At 1-yr follow-up
for those who obtained initial reduction of MR of 2 grades or more, pts
with no or mild MAC retained the reduction in 86/99 (86.9%) in-
stances, while pts with moderate or severe MAC retained the reduc-
tion in 14/15 (93.3%) instances (p¼0.690). Procedural success of
reduction of MR  mild-to-moderate was obtained in 69/87 (79.3%)
pts with no MAC, 52/61 (85.2%) pts with mild MAC, and 22/25 (88.0%)
pts with moderate-to-severe MAC (p¼0.481). At 1-yr follow up for
those who obtained initial reduction of MR  mild-to-moderate, pts
with no or mild MAC retained the reduction in 67/86 (77.9%) in-
stances, while pts with moderate or severe MAC retained the reduc-
tion in 11/14 (78.6%) instances (p¼1.000).
CONCLUSIONS MAC does not impact MitraClip procedural success in
percutaneous edge-to-edge MR repair despite increased age in ptswith MAC. Procedural success is high across MAC severities and MAC
alone should not preclude percutaneous edge-to-edge repair of MR.
Moreover, moderate or severe MAC, which may make surgical repair
of MR challenging, is not associated with decreased durability of
percutaneous repair. Further investigations are warranted to explore
this relationship.
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Immediate and long term outcomes after repeat percutaneous mitral
valvuloplasty for patients with mitral valve restenosis
Bahaa Alhabil1
1Institut Mutualiste Montsouris, Paris, HI
BACKGROUND Only rare reports have been published about redo
PMV and data regarding its long term safety and efﬁcacy are scarce. So
we decided to explore the immediate and long-term outcomes of
repeat (redo) percutaneous mitral valvuloplasty (PMV) in a series of
patients with mitral restenosis in comparison with initial PMV in the
same series and to determine prognostic factors of outcomes.
METHODS A retrospective study enrolling a population of 170 pa-
tients treated by PMV in the university hospital Habib Thameur,
Tunisia, between January 1997 and January 2011. The study group
consisted of 50 patients (mean age 4710 years) who underwent a
redo PMV. All redo PMV procedures were performed using the Inoue
balloon system. Procedural success was deﬁned as 50% or more in-
crease of mitral valve area (MVA) with a ﬁnal MVA 1.5 cm2, without
major complications. Restenosis was deﬁned as loss of >50% of the
initial gain of MVA by the preceding PMV with a ﬁnal MVA <1.5 cm2.
RESULTS Successful procedural result was achieved in 81.1% of pa-
tients. There were no in-hospital complications. Both the initial and
redo procedures were similar concerning the ﬁnal increase of mitral
valve area, the decrease of mean transmitral pressure gradient and the
mean pulmonary artery pressure (P<0.001 for all). The Procedural
success and the gain of MVA were higher in the initial as compared to
the redo procedure (P<0.05). The only independent predictor of redo
PMV success was an echocardiographic score <8. Early symptomatic
improvement after redo PMV of 1 NYHA functional class was ob-
tained in 95% of the patients. The mean follow-up was 80, 8535
months. There were no deaths and restenosis was noted in 40%. Eight
(16%) patients required mitral valve replacement (34.21 months after
redo PMV) due to recurrent symptoms. The predictive factors of
restenosis identiﬁed by the univariate analysis in our study were:
previous surgical commissurotomy (p¼0.01) and a high echocardio-
graphic score (p¼0.028).
CONCLUSIONS Repeat PMV is safe and provides good immediate re-
sults in patients with restenosis after successful ﬁrst procedure. Long-
term results of redo PMV are satisfactory and related mainly to the
echo score.
CATEGORIES STRUCTURAL: Valvular Disease: Mitral
TCT-706
Sustained improvement of mitral regurgitation and symptoms after
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BACKGROUND Percutaneous mitral valve repair (PMVR) using the
MitraClip-system has become a valid alternative for patients with
severe mitral regurgitation (MR) and high surgical risk. For a lack of
evidence deriving from randomized trials, data from high volume
registries is therefore of interest. Herein, we report the results of the
